Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin

Area of Science:

• Oncology
• Materials Science
• Pharmacology

Background:

• Liver cancer is a leading cause of cancer mortality worldwide.
• Norcantharidin (NCTD) shows efficacy against primary liver cancer but has urinary system toxicity.
• Targeted drug delivery systems are needed to improve liver cancer treatment and reduce side effects.

Purpose of the Study:

• To develop and evaluate novel polymer micelles for targeted liver drug delivery.
• To investigate the efficacy of NCTD-loaded micelles (NCTD-M) for liver cancer treatment.
• To assess the potential of NCTD-M to enhance antitumor activity and reduce systemic toxicity.

Main Methods:

• Preparation of arabinogalactan-coated N-(4-methylimidazole)-hydroxyethyl-chitosan (MHC) polymer micelles loaded with NCTD.
• In vitro studies using HepG2 cells to analyze cytotoxicity, invasion, apoptosis, and cellular uptake.
• In vivo evaluation of NCTD-M antitumor efficacy in tumor-bearing nude mice using imaging and efficacy studies.

Main Results:

• Successfully prepared NCTD-loaded MHC micelles (NCTD-M) with positive liver-targeting capabilities.
• In vivo imaging confirmed enhanced drug accumulation in the liver.
• In vitro and in vivo studies demonstrated increased cellular uptake, enhanced cell invasion, elevated apoptosis, and superior antitumor effects of NCTD-M compared to controls.

Conclusions:

• The developed liver-targeting NCTD-M effectively deliver drugs to the liver, enhancing antitumor efficacy.
• NCTD-M show potential for reducing toxicity associated with NCTD treatment.
• This targeted drug delivery system represents a promising therapeutic strategy for liver cancer.